Chemplast Sanmar Limited

Consecutive quarterly losses of ₹35–₹883 Cr across 9 of 10 recent quarters; verify whether these reflect temporary demand disruption, input cost inflation, or structural margin compression in key product segments

Operating margins have swung from +15.48% to −10.19% in consecutive quarters, indicating volatility in pricing, costs, or product mix; clarify whether this reflects cyclical market conditions or operational instability

Negative ROE of −14.64% means shareholder capital is being destroyed; combined with D/E of 1.11, refinancing risk rises if losses persist—check debt maturity, covenant triggers, and lender appetite

Stock price fell 55.2% in one year with a 52-week range of ₹171.68–₹455.05; verify whether this reflects cyclical recovery already priced out or sustained fundamental deterioration

Consolidated quarterly revenue of ₹1,000–₹1,250 Cr (Mar–Jun 2026) establishes operational scale; restoring operating margins to the 13–15% achieved in Mar 2026 would generate ₹150+ Cr quarterly operating profit, eliminating current ₹100+ Cr quarterly losses

Operating margins achieved +3–15% in recent quarters, proving the business can be profitable; stabilization of margins above 10% would restore positive ROE and address the current −14.64% capital destruction

Specialty chemicals sector in India typically benefits from industrial growth and export expansion; verify whether company participates in export markets, holds positions in high-margin segments, or has recent capex supporting margin recovery